Market Access/ News/ News Amicus’ oral Fabry disease drug approved in US Richard Staines Amicus Therapeutics, Fabry disease, FDA approval, Galafold, rare disease 0 Comment Decision follows approval in Europe Share X Amicus’ oral Fabry disease drug approved in US https://pharmaphorum.com/news/amicus-oral-fabry-disease-drug-approved/
News/ News/ R&D Orphan drugs dominate 2018 UK Prix Galien shortlist Dominic Tyer Amicus, Galafold, Innovation, medtech, Medtronic, orphan drugs, Prix Galien, Rare diseases, UK Prix Galien 0 Comment A bumper crop of orphan drugs from the likes of Amicus, Kyowa Kirin, Eusa and Biogen dominates this Share X Orphan drugs dominate 2018 UK Prix Galien shortlist https://pharmaphorum.com/news/orphan-drugs-uk-prix-galien-shortlist/